Pubertal development in 46,XY patients with NR5A1 mutations.
Isabel MönigJulia SchneidewindTrine Holm JohannsenAnders JuulRalf WernerRalf LünstedtWiebke BirnbaumLouise MarshallLutz WünschOlaf HiortPublished in: Endocrine (2021)
Patients with NR5A1 mutations regardless of phenotype at birth may demonstrate considerable virilization at puberty. Therefore, it is important to consider sex assignment carefully and avoid irreversible procedures during infancy.
Keyphrases